Concurrent Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.97M Sell
46,569
-748
-2% -$66.7K 0.04% 414
2025
Q4
$3.74M Buy
47,317
+20,486
+76% +$1.61M 0.04% 399
2025
Q3
$2.14M Buy
26,831
+1,974
+8% +$168K 0.04% 445
2025
Q2
$2.26M Buy
24,857
+2,449
+11% +$224K 0.04% 399
2025
Q1
$2.1M Buy
22,408
+11,131
+99% +$997K 0.05% 357
2024
Q4
$1.03M Sell
11,277
-1,306
-10% -$125K 0.03% 478
2024
Q3
$1.31M Buy
12,583
+867
+7% +$88.4K 0.04% 411
2024
Q2
$1.14M Buy
11,716
+2,565
+28% +$237K 0.04% 398
2024
Q1
$824K Sell
9,151
-1,486
-14% -$126K 0.03% 418
2023
Q4
$848K Buy
+10,637
New +$800K 0.04% 361

Other funds holding CL

Concurrent Investment Advisors's CL Position: Q1 2026 in Review

Concurrent Investment Advisors reduced its Colgate-Palmolive (CL) stake by 1.6% in Q1 2026, selling an estimated $66.7K and leaving 46,569 shares worth $3.97M. The position accounts for 0.04% of the portfolio, ranked #414.

Concurrent Investment Advisors first reported a position in CL in Q4 2023 and has held it in 10 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Concurrent Investment Advisors held 46,569 shares of Colgate-Palmolive worth $3.97M as of Q1 2026.
  • Concurrent Investment Advisors sold 748 Colgate-Palmolive shares in Q1 2026, an estimated $66.7K.
  • Colgate-Palmolive made up 0.04% of Concurrent Investment Advisors's portfolio in Q1 2026, its #414 holding.
  • Concurrent Investment Advisors first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 10 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.